Tibra Equities Europe’s Enliven Therapeutics ELVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-9,375
Closed -$296K 89
2021
Q2
$296K Buy
+9,375
New +$296K 0.09% 185